Japan Compassionate Use System

Regulatory Framework

Pharmaceutical Affairs Law Article 80

Eligibility Criteria

Serious life-threatening disease with no approved treatment in Japan; drug under development or approved overseas; clinical trial participation not possible; physician determines medical necessity; institutional review board approval

Available Drugs (0)

No drugs linked to this program.